Main menu

You are here

Covid: New research suggests Novovax NVX-CoV2373 booster vaccine is effective against SARS-CoV-2 Omicron subvariants

Primary tabs

Tue, 2022-11-01 09:51 — mike kraft

New research suggests booster dose of Novovax NVX-CoV2373 vaccine is effective against SARS-CoV-2 Omicron subvariants A new study evaluated the neutralizing antibody titers against the SARS-CoV-2 Omicron variant and its sub-lineages after two and three doses of the Novovax protein nanoparticle vaccine NVX-CoV2373. News-Medical.net

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

- Private group -

Log in or register to post comments

Page loaded in 0.420 seconds.